Advantage of partnering with MCTC

Optimal site selection

  • Global directory of myositis investigators, sites, and patients

  • Coordinated network of reliable site investigators with validated expertise in myositis clinical trials

  • Access to consolidated information to enhance informed site selection

  • Targeted initiatives to streamline site selection and initiation
    ✓ Facilitation of introduction to potential study site investigators
    ✓ Training materials and certification on core myositis instruments and assessments
    ✓ Improved transparency and uniformity in budgeting, start-up, etc.

Enhanced trial recruitment

  • Multiple medical centers across the world

  • Community of traditional research trial sites coupled to collaborating regional sites/partners

  • Ethnic, racial, and geographically diverse population

  • Decreased competing overlap in recruitment amongst multiple trials and sites

  • Buy-in from prominent leaders in myositis clinical research and patient groups from a broad cross-section of medical disciplines and geography

Connect with international myositis experts

  • Consultation with MCTC’s multidisciplinary physician team

  • Enhanced coordination amongst consortium members, including shared best practices

  • Training and certification for investigators/clinical research team

Key stakeholders buy-in

  • Integration of multiple stakeholders, including non-physician myositis experts, clinical research coordinators, patient advocacy groups, etc.